Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characteristics and outcomes of Black patients with wild type transthyretin cardiac amyloidosis.

Cardiovascular revascularization medicine : including molecular interventions - 1 Dec 2025

Li Jason Z, Njus Meredith M, Oates Connor P, Vora Tania A, Kadakkal Ajay, Afari-Armah Nana, Barish Rachel M, Sheikh Farooq H

Abstract excerpt

BACKGROUND: The clinical characteristics and outcomes of Black patients with wild type transthyretin cardiac amyloidosis (ATTRwt-CA) are not well described in the literature. METHODS: We conducted a single center retrospective cohort study of 186 patients with cardiac amyloidosis, of which 62 had ATTRwt-CA, diagnosed at our institution between 2/2010 and 4/2023. We compared clinical, laboratory,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathies

Share to Cause of Death

Share to Health Status Disparities

Share to Prealbumin

Share to Risk Assessment

Share to Time Factors

Source

Identifiers

PMID: 40374482
DOI: 10.1016/j.carrev.2025.05.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characteristics and outcomes of Black patients with wild type transthyretin cardiac amyloidosis.PMID 40374482Read ↗

Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis.Semantic proximity Read ↗

Transthyretin Cardiac Amyloidosis in Black Americans.Semantic proximity Read ↗

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.Semantic proximity Read ↗

Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study.Semantic proximity Read ↗

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)Semantic proximity Read ↗

Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program.Semantic proximity Read ↗

Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes.Semantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Prevalence, Characteristics and Outcomes of Older Patients with Hereditary Versus Wild-Type Transthyretin Amyloid CardiomyopathySemantic proximity Read ↗

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Semantic proximity Read ↗

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population.Semantic proximity Read ↗

Transthyretin amyloidosis cardiomyopathy in Greece: Clinical insights from the National Referral Center.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.